Annals of internal medicine
-
This article has been corrected. The original version (PDF) is appended to this article as a Supplement.
-
This article has been corrected. The original version (PDF) is appended to this article as a Supplement.
-
This article has been corrected. The original version (PDF) is appended to this article as a Supplement.
-
Multicenter Study
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
The potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncertain. ⋯ Bayer Hispania.
-
This article has been corrected. The original version (PDF) is appended to this article as a Supplement.